Adlai Nortye IPO gives old Novartis cancer drug new life

cafead

Administrator
Staff member
  • cafead   Sep 29, 2023 at 10:33: AM
via Cancer drug developer Adlai Nortye on Thursday raised $57.5 million in an initial public offering, becoming the 16th biotechnology company to debut on a U.S. stock exchange this year, according to BioPharma Dive data.

article source